Sera Prognostics (NASDAQ:SERA) Stock, Quote.MetaTitle.unusual-options

Sera Prognostics

Sera Prognostics, Inc. - Class A Common Stock

Sera Prognostics Inc

Serabi Gold PLC

Adicet Bio

Adverum Biotechnologies, Inc. - Common Stock

Adverum Biotechnologies

Artiva Biotherapeutics, Inc. - Common Stock

Artiva Biotherapeutics

Atossa Therapeutics

Atara Biotherapeutics, Inc. - Common Stock

Atara Biotherapeutics

Biomea Fusion

Clene

Estrella Immunopharma, Inc. - Common Stock

Estrella Immunopharma

Gain Therapeutics

InflaRx

Immix Biopharma

Kalaris Therapeutics, Inc. - Common Stock

Kalaris Therapeutics

Karyopharm Therapeutics Inc. - Common Stock

Karyopharm Therapeutics

Macrogenics

OKYO Pharma

Oncolytics Biotech

Ovid Therapeutics

Pelthos Therapeutics

Quince Therapeutics

Surrozen

Shattuck Labs

Instil Bio

Tevogen Bio Holdings

Whitehawk Therapeutics, Inc. - Common Stock

Whitehawk Therapeutics

Zentalis Pharmaceuticals, Inc. - common stock

Zentalis Pharma

Prévisions Sera Prognostics (SERA)

Actualités

Gains

Quote.Nav.option-chain

Évaluations des analystes

Transactions internes

Intérêt court

Rapport sur les stocks

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

Comments

Sera Prognostics Options Inhabitueles

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL